Cargando…
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although several FDA-approved drugs are currently under clinical trials for drug repositioning, there is an on-going global effort for new drug identification. In this paper, using multi-omics (interactome, p...
Autores principales: | Barh, Debmalya, Tiwari, Sandeep, Weener, Marianna E., Azevedo, Vasco, Góes-Neto, Aristóteles, Gromiha, M. Michael, Ghosh, Preetam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547373/ https://www.ncbi.nlm.nih.gov/pubmed/33131530 http://dx.doi.org/10.1016/j.compbiomed.2020.104051 |
Ejemplares similares
-
The Spike of SARS-CoV-2: Uniqueness and Applications
por: Kumavath, Ranjith, et al.
Publicado: (2021) -
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain
por: Barh, Debmalya, et al.
Publicado: (2020) -
Comparative mangrove metagenome reveals global prevalence of heavy metals and antibiotic resistome across different ecosystems
por: Imchen, Madangchanok, et al.
Publicado: (2018) -
Linking common non-coding RNAs of human lung cancer and M. tuberculosis
por: Barh, Debmalya, et al.
Publicado: (2018) -
Computational screening for potential drug candidates against the SARS-CoV-2 main protease
por: Silva Andrade, Bruno, et al.
Publicado: (2020)